The past decade has seen two of the three biggest buyouts in the Indian pharmaceutical industry – Sun Pharmaceutical Industries Ltd.’s acquisition of Ranbaxy Laboratories Ltd. and Abbott Laboratories Inc.’s deal for the erstwhile Piramal Healthcare Ltd.'s (now Piramal Enterprises Ltd.) generics business.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?